Generex Biotechnology Corp. (GNBT)
Generex Biotechnology Corporation engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company’s primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Glucose RapidSpray that delivers glucose through a pump spray to the mouth, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the...
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
Contact Information:
| Business Address: | - |
| Mailing Address: | 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2 Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551 |
| Phone: | 416-364-2551 |
| Fax: | 416-364-9363 |
| Website: | http://www.generex.com |
Company Details:
| Symbol: | GNBT |
| SIC: | - |
| State location: | A1 |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 43 |
| Type: | OTCBB |
Key executives:
| Name | Age | Position |
|---|---|---|
| Anna E. Gluskin | 61 | Chairman, Chief Exec. Officer and Pres |
| Eric Von Hofe Ph.D. | - | Pres of Antigen Express |
| Gerald Bernstein M.D. | 79 | VP of Medical Affairs |
| Mark Fletcher Esq. | 46 | Exec. VP and Gen. Counsel |
| Rose C. Perri | 45 | Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer |
Generex Biotechnology Corp. (OTC:GNBT) Keeps Running Up Jan 18, 2012
Generex Biotechnology Corp. (OTC:GNBT) has been climbing up fast over the past days. Yesterday, the stock soared another 13.48% on a traded volume of over 9 million shares.read more
Generex Biotechnology Corp. (OTC:GNBT) Still Trades Massively Dec 20, 2011
Generex Biotechnology Corp. (OTC:GNBT) has been climbing up since last week. Yesterday, the up move continued and the stock added another 18.24% to its price, while its traded volume reached approximately 11 million shares.read more
Generex Biotechnology Corp. (OTC:GNBT) Climbs Up on Hot News Dec 9, 2011
Generex Biotechnology Corp. (OTC:GNBT) has been moving up since Tuesday. Yesterday, the stock price jumped up 16.67% and its traded volume exceeded 7 million shares.read more
Generex Biotechnology Corp. (OTC:GNBT) Stock Fell Down Again Aug 11, 2011
Yesterday, Generex Biotechnology Corp. (OTC:GNBT) broke up the climb and took the way down again. The stock lost 2.54% for the day and its traded volume substantially decreased.read more
Generex Biotechnology Corp. (OTC:GNBT) Bounces Up from the Bottom Aug 10, 2011
At the beginning of the week, the long-lasting downtrend of Generex Biotechnology Corp. (OTC:GNBT) stock resulted in a new bottom for the share price. Although GNBT recovered the losses yesterday, it looks like the company fails to meet investor expectations recently, and keeps silent on certain important for shareholders issues.read more
New product tease rewards TEGY traders with a 45% gain Dec 16, 2010, 15:52
New product tease rewards TEGY traders with a 45% gain
TEGY Adds Some New Power Technologies to its Platform, and the Market Applauds!
Good Afternoon!
We knew that Transact Energy Corp. (TEGY) tends to make large and sudden moves, but this morning's 45% bounce was a lot more satisfying than we expected!
After TEGY announced that it's talking about licensing read more
| Promoter: BeaconEquity.com | Paying Party: Emerging Equity Advisors | Max Profit: Pending | Gain at close: Pending |
| Stock: TEGY | Compensation: $50,000 | Avg $ Volume for Period: UNKNOWN | |
| Stock: GNBT | Compensation: $90,000 | Avg $ Volume for Period: UNKNOWN | |
=?WINDOWS-1252?Q?GNBT_is_being_accumulated_ Dec 16, 2010, 09:41
GNBT is being accumulated – FAST!
Trade Alert: Generex Biotechnology Corp. (GNBT)
GNBT is 83% Off Recent Highs – But Now Reversing Course as FDA Approval is Sought!
Good Morning Hideout Trader!
The future of Generex Biotechnology Corporation (GNBT) which develops drug delivery systems and technologies is looking mighty bright again!
The read more
| Promoter: Stock Hideout | Paying Party: Emerging Equity Advisors | Max Profit: Pending | Gain at close: Pending |
| Stock: GNBT | Compensation: $90,000 BlueWave Advisors, LLC owns seventy five percent of the outstanding membership interests of StockHideout LLC. Stock_Analyzer owns twenty five percent of the outstanding membership interests of StockHideout, LLC. BlueWave Advisors has been compensated ninety thousand dollars from Emerging Equity Advisors, Inc. - non-controlling 3rd party sh | Avg $ Volume for Period: UNKNOWN | |
PennyStockProphet - GNBT - Thursday! Dec 16, 2010, 09:20
PSP Members, I've got a bio-tech pick for us today that's picking up enormous momentum as it appears ready to bounce of it's 52-week low! This is a NASDAQ quality company currently trading at penny stock prices, and it's time to take advantage of it! The company's current 10-day trading average is over 1.3 Million shares per day and climbing! Volume has been picking up every day since Monday, and the company just announced yesterday a new patent read more
| Promoter: Penny Stock Prophet | Paying Party: UNKNOWN | Max Profit: Pending | Gain at close: Pending |
| Stock: GNBT | Compensation: Unknown compensation | Avg $ Volume for Period: UNKNOWN | |